User: Guest

LUNG CANCER DIAGNOSTICS

Global Market Trajectory & Analytics

MCP16923

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

3123
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

562
Interactions with Platform & by Email

PARTICIPANTS

94
Unique # Participated

VALIDATIONS

42
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEPTEMBER 2020

TABLES

306

PAGES

605

EDITION

8

PRICE

USD $5450


The global market for Lung Cancer Diagnostics is projected to reach US$3.2 billion by 2025, driven by rising incidence and growing economic burden of lung cancer in terms of survival rates and medical expenditure. Rising environmental pollution is taking its toll on the health of the population. Among the many factors attributed to the epidemic spread of cancer is the rising air pollution as evidenced by unchecked presence of particulate matter (PM10 and PM2.5) in outdoor and indoor air. Increase in the cacogenic load in the environment is catalyzing the prevalence of all types of cancers. Exposure to particulate matter (PM2.5) in the air as a result of deteriorating air quality in global cities is a key reason amplifying the incidence and prevalence of lung cancer. Thousands of cities today have air pollution significantly higher than the safe levels established by WHO, exposing billions of people around the world to dangerous air. Over 8.5 million deaths occur each year due to exposure to fine particles in polluted air, with lung cancer leading the mortality rate.

Against the backdrop of the emerging picture of disease severity, there is growing focus shed on early detection, diagnosis and supportive treatment. Given that any cancer when detected at an early stage before it has spread has a higher likelihood of being successfully treated, there is strong focus shed on lung cancer screening. Screening provides new hope for early detection and more successful treatment of lung cancer. As compared to other cancers, survival rates associated with lung cancer is low and the disease is often identified only at advanced stages since symptoms closely mimic those associated with infections, emphysema, COPD and smoking thereby leading to misdiagnosis. Currently gaining significance is a low-dose CAT scan (LDCT) with research studies proving the diagnostic technique to be effective in identifying abnormal lesions in the lungs in high risk patients. Also a growth driver is the expanding base of high risk population which includes aging people in the 60+ age group, growing number of smokers, rise in COPD which is a major risk factor for cancer and premature lung aging.

A key sector of the market poised to witness above average growth is the emerging field of liquid biopsies. Until recently, testing for mutations was carried out only by tissue-biopsy-based testing which is ridden with challenges and clinical inefficiency. Tissue biopsies are effective in confirming a diagnosis and identifying corresponding molecular abnormalities. However, the test does not offer the in-depth understanding of the tumor which is required for timely and effective treatment. Liquid biopsy, on the other hand, enhances the effectiveness of the treatment of NSCLC, with the ability to circumvent all the biological limitations of tissue biopsy. A key of benefit of liquid biopsies will however be a reduction in the number of unrequired and unnecessary tissue biopsies. This is a significant advantage especially in the current era of value based care which aims to reduce healthcare wastages. The benefit in healthcare cost savings can be put into perspective by the fact that in the United States in the breast cancer sector alone over 1.5 million breast tissue biopsies are performed annually with only 25% of these tests resulting in a confirmatory cancer diagnosis. Liquid biopsies given their ability provide greater diagnostic insights can help close the wastages involved in cancer diagnosis. The United States and Europe represent large markets worldwide with a combined share of 49.3% of the global market. China ranks as the fastest growing market with a CAGR of 11.4% over the analysis period supported by rising incidence of lung cancer as a result of diversity in lifestyles and socioeconomic development including occupational factors.
Abbott Diagnostics - Core Laboratory; Dr Lal PathLabs; F. Hoffmann-La Roche AG; Illumina Inc.; Myriad Genetics Inc.; NanoString Technologies; NeoGenomics Laboratories Inc.; PlexBio Co., Ltd.; QIAGEN GmbH; Quest Diagnostics; Thermo Fisher Scientific Inc.
» Test (Imaging Tests, Sputum Cytology, Molecular Tests, Biopsy, and Other Tests) » Type (Non-Small-Cell Lung Cancer (NSCLC), and Small-Cell Lung Cancer (SCLC) » and End-Use (Hospital Laboratories, Cancer Research Institutes, and Other End-Uses)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Early Detection of Lung Cancer Takes Precedence, Driving the Demand for Lung Cancer Diagnostics
Non-small Cell Lung Cancer - The More Prominent of the Two Lung Cancer Types
Imaging Tests Segment Dominates the Market, Molecular Tests Category to Witness High Growth
US Leads the Lung Cancer Diagnostics Market, Asia-Pacific to Witness Fastest Growth
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Agilent Technologies Inc. (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Illumina, Inc. (USA)
NeoGenomics Laboratories, Inc. (USA)
QIAGEN N.V. (The Netherlands)
Thermo Fisher Scientific, Inc. (USA)
Veracyte (USA)
3. MARKET TRENDS & DRIVERS
Increasing Prevalence and Incidence of Lung Cancer to Push the Demand for Early Diagnoses
Age-Standardized Lung Cancer Rates for Select Countries
Age-Standardized Lung Cancer Rates in Men for Select Countries
Age Standardized Lung Cancer Rates in Women for Select Countries
Lung Cancer-Specific Biomarkers to Spur Market Growth
Select Lung Cancer Biomarkers
New Potential Biomarker for Early Stage Lung Cancer Identified in a Recent NCI Study (2019)
Advancements and Research Initiatives in Lung Cancer Diagnostics Space
EFIRM Test for Detection of Lung Cancer-related EGFR Mutations in NSCLC Patients
A Glance at Select Recent Launches of Lung Cancer Diagnostic Tests
New Product Launches/Approvals in the Lung Cancer Diagnostics
Recent Approvals
Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
Effervescent Rate of New Innovations & Product Development Will Make Liquid Biopsy a Readily Available Option for Patients in the Coming Years
High Cigarette Consumption/Rise in Prevalence of Smoking Increases the Incidence of Lung Cancer
Cigarette Consumption Per Year Per Person Across Select Countries: 2016
Top 15 Countries with the Highest Smoking Rates: 2015
Increasing Number of Awareness Programs for Lung Cancer and Symptoms
Growing Availability of Government/Private Funding for R&D to Develop Lung Cancer Diagnostics
Table: National Cancer Institute Research Funding for Lung Cancer in US$ Million for the Years 2014 through 2017
Aging Demographics & Unhealthy Lifestyles Raise the Risk of Cancer
Cancer Prone Sites based on Age
Table: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
Lung Cancer Diagnostics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
Lung Cancer Diagnostics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
Lung Cancer Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Imaging Tests (Test) World Market by Region/Country in US$ Thousand: 2020 to 2027
Imaging Tests (Test) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
Imaging Tests (Test) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Sputum Cytology (Test) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
Sputum Cytology (Test) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
Sputum Cytology (Test) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Molecular Tests (Test) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
Molecular Tests (Test) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
Molecular Tests (Test) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Biopsy (Test) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
Biopsy (Test) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019
Biopsy (Test) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Other Tests (Test) World Market by Region/Country in US$ Thousand: 2020 to 2027
Other Tests (Test) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
Other Tests (Test) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Non-Small-Cell Lung Cancer (NSCLC) (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027
Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2012 to 2019
Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
Small-Cell Lung Cancer (SCLC) (Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027
Small-Cell Lung Cancer (SCLC) (Type) Global Historic Demand in US$ Thousand by Region/Country: 2012 to 2019
Small-Cell Lung Cancer (SCLC) (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Hospital Laboratories (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
Hospital Laboratories (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019
Hospital Laboratories (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
Cancer Research Institutes (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
Cancer Research Institutes (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019
Cancer Research Institutes (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Other End-Uses (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
Other End-Uses (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
Other End-Uses (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
United States
Lung Cancer Stats
US Lung and Bronchus Cancer New Cases by Gender: 2019E
US Lung and Bronchus Cancer Deaths by Gender: 2019E
Incidence Rates* for Lung and Bronchus Cancer by Gender, 2011-2015
Death Rates* for Lung and Bronchus Cancer by Gender in the US, 2012-2016
Incidence Rates for Lung and Bronchus Cancer by Race/Ethnicity, 2011-2015
Reimbursement and Insurance Coverage for Lung Cancer Screening in the US
CY 2019 Medicare Physician Fee Payment Levels for Low Dose CT Scan (LDCT) Screening
CY 2019 Hospital Outpatient Prospective Payment System (HOPPS) Payment Levels for Low Dose CT Scan (LDCT) Screening
Oncimmunes EarlyCDT Lung to be commercialized in the US by Biodesix (2019)
Market Analytics
United States Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2020 to 2027
Lung Cancer Diagnostics Market in the United States by Test: A Historic Review in US$ Thousand for 2012-2019
United States Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
United States Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
Lung Cancer Diagnostics Market in the United States by Type: A Historic Review in US$ Thousand for 2012-2019
United States Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
United States Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019
Lung Cancer Diagnostics Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
Canada
Canadian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020 to 2027
Canadian Lung Cancer Diagnostics Historic Market Review by Test in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Test for 2012, 2020, and 2027
Canadian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
Canadian Lung Cancer Diagnostics Historic Market Review by Type in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
Canadian Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
Canadian Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Japan
Japanese Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Market in Japan: Historic Sales Analysis in US$ Thousand by Test for the Period 2012-2019
Japanese Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
Japanese Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
Japanese Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
Japanese Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Japanese Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
China
Chinese Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in China in US$ Thousand by Test: 2012-2019
Chinese Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2012, 2020, and 2027
Chinese Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in China in US$ Thousand by Type: 2012-2019
Chinese Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Chinese Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market Review in China in US$ Thousand by End-Use: 2012-2019
Chinese Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
Europe
European Lung Cancer Diagnostics Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
Lung Cancer Diagnostics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
European Lung Cancer Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020-2027
Lung Cancer Diagnostics Market in Europe in US$ Thousand by Test: A Historic Review for the Period 2012-2019
European Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
European Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
Lung Cancer Diagnostics Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019
European Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
European Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
Lung Cancer Diagnostics Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
European Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
France
Lung Cancer Diagnostics Market in France by Test: Estimates and Projections in US$ Thousand for the Period 2020-2027
French Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Test: 2012-2019
French Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
French Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Type: 2012-2019
French Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
French Lung Cancer Diagnostics Historic Market Review in US$ Thousand by End-Use: 2012-2019
French Lung Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
Germany
Lung Cancer Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2020-2027
German Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2012-2019
German Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
German Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2012-2019
German Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
German Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
Italy
Italian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in Italy in US$ Thousand by Test: 2012-2019
Italian Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2012, 2020, and 2027
Italian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in Italy in US$ Thousand by Type: 2012-2019
Italian Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Italian Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market Review in Italy in US$ Thousand by End-Use: 2012-2019
Italian Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
United Kingdom
TABLE: UK Age-standardised Rate (per 100,00) of Lung Cancer Cases by Gender: 1980-2035P
United Kingdom Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Test for the Period 2012-2019
United Kingdom Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
United Kingdom Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
United Kingdom Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
United Kingdom Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
United Kingdom Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
Spain
Spanish Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020 to 2027
Spanish Lung Cancer Diagnostics Historic Market Review by Test in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Test for 2012, 2020, and 2027
Spanish Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
Spanish Lung Cancer Diagnostics Historic Market Review by Type in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
Spanish Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
Spanish Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Russia
Russian Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2020 to 2027
Lung Cancer Diagnostics Market in Russia by Test: A Historic Review in US$ Thousand for 2012-2019
Russian Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Russian Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
Lung Cancer Diagnostics Market in Russia by Type: A Historic Review in US$ Thousand for 2012-2019
Russian Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Russian Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Historic Demand Patterns in Russia by End-Use in US$ Thousand for 2012-2019
Lung Cancer Diagnostics Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027
Rest of Europe
Rest of Europe Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020-2027
Lung Cancer Diagnostics Market in Rest of Europe in US$ Thousand by Test: A Historic Review for the Period 2012-2019
Rest of Europe Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Rest of Europe Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
Lung Cancer Diagnostics Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019
Rest of Europe Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Rest of Europe Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
Lung Cancer Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
Rest of Europe Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Asia-Pacific
Asia-Pacific Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
Lung Cancer Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019
Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Asia-Pacific by Test: Estimates and Projections in US$ Thousand for the Period 2020-2027
Asia-Pacific Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Test: 2012-2019
Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
Asia-Pacific Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Type: 2012-2019
Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
Asia-Pacific Lung Cancer Diagnostics Historic Market Review in US$ Thousand by End-Use: 2012-2019
Asia-Pacific Lung Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
Australia
Lung Cancer Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2020-2027
Australian Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2012-2019
Australian Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
Australian Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2012-2019
Australian Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
Australian Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
India
Rise in Incidence of Lung Cancer in India
Table: New Cancer Cases in India by Site: 2018
Indian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020 to 2027
Indian Lung Cancer Diagnostics Historic Market Review by Test in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in India: Percentage Share Breakdown of Sales by Test for 2012, 2020, and 2027
Indian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
Indian Lung Cancer Diagnostics Historic Market Review by Type in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
Indian Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market in India: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
Indian Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
South Korea
Lung Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2020-2027
South Korean Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in South Korea by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
South Korean Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2020-2027
South Korean Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
Rest of Asia-Pacific
Rest of Asia-Pacific Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Test for the Period 2012-2019
Rest of Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
Rest of Asia-Pacific Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
Rest of Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
Rest of Asia-Pacific Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Rest of Asia-Pacific Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
Latin America
Latin American Lung Cancer Diagnostics Market Trends by Region/Country in US$ Thousand: 2020-2027
Lung Cancer Diagnostics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019
Latin American Lung Cancer Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
Latin American Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in Latin America in US$ Thousand by Test: 2012-2019
Latin American Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2012, 2020, and 2027
Latin American Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in Latin America in US$ Thousand by Type: 2012-2019
Latin American Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Latin American Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market Review in Latin America in US$ Thousand by End-Use: 2012-2019
Latin American Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
Argentina
Argentinean Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020-2027
Lung Cancer Diagnostics Market in Argentina in US$ Thousand by Test: A Historic Review for the Period 2012-2019
Argentinean Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Argentinean Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
Lung Cancer Diagnostics Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2012-2019
Argentinean Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Argentinean Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
Lung Cancer Diagnostics Market in Argentina: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
Argentinean Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Brazil
Lung Cancer Diagnostics Market in Brazil by Test: Estimates and Projections in US$ Thousand for the Period 2020-2027
Brazilian Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Test: 2012-2019
Brazilian Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
Brazilian Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Type: 2012-2019
Brazilian Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Quantitative Demand Analysis in Brazil in US$ Thousand by End-Use: 2020-2027
Brazilian Lung Cancer Diagnostics Historic Market Review in US$ Thousand by End-Use: 2012-2019
Brazilian Lung Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
Mexico
Lung Cancer Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2020-2027
Mexican Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2012-2019
Mexican Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
Mexican Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2012-2019
Mexican Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
Mexican Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
Rest of Latin America
Rest of Latin America Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2020 to 2027
Lung Cancer Diagnostics Market in Rest of Latin America by Test: A Historic Review in US$ Thousand for 2012-2019
Rest of Latin America Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Rest of Latin America Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
Lung Cancer Diagnostics Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2012-2019
Rest of Latin America Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Rest of Latin America Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Historic Demand Patterns in Rest of Latin America by End-Use in US$ Thousand for 2012-2019
Lung Cancer Diagnostics Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
Middle East
The Middle East Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
Lung Cancer Diagnostics Market in the Middle East by Region/Country in US$ Thousand: 2012-2019
The Middle East Lung Cancer Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
The Middle East Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020 to 2027
The Middle East Lung Cancer Diagnostics Historic Market by Test in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Test for 2012,2020, and 2027
The Middle East Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
The Middle East Lung Cancer Diagnostics Historic Market by Type in US$ Thousand: 2012-2019
Lung Cancer Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and 2027
The Middle East Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
The Middle East Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Iran
Iranian Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Market in Iran: Historic Sales Analysis in US$ Thousand by Test for the Period 2012-2019
Iranian Lung Cancer Diagnostics Market Share Analysis by Test: 2012 VS 2020 VS 2027
Iranian Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
Iranian Lung Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
Iranian Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Iranian Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027
Israel
Israeli Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2020-2027
Lung Cancer Diagnostics Market in Israel in US$ Thousand by Test: A Historic Review for the Period 2012-2019
Israeli Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Israeli Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
Lung Cancer Diagnostics Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2012-2019
Israeli Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Israeli Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
Lung Cancer Diagnostics Market in Israel: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
Israeli Lung Cancer Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Saudi Arabia
Saudi Arabian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in Saudi Arabia in US$ Thousand by Test: 2012-2019
Saudi Arabian Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2012, 2020, and 2027
Saudi Arabian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
Lung Cancer Diagnostics Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2012-2019
Saudi Arabian Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Saudi Arabian Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Market Review in Saudi Arabia in US$ Thousand by End-Use: 2012-2019
Saudi Arabian Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
United Arab Emirates
Lung Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2020-2027
United Arab Emirates Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in United Arab Emirates by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
United Arab Emirates Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2020-2027
United Arab Emirates Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
Rest of Middle East
Lung Cancer Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2020-2027
Rest of Middle East Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2012-2019
Rest of Middle East Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
Rest of Middle East Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2012-2019
Rest of Middle East Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
Lung Cancer Diagnostics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
Rest of Middle East Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2012-2019
Lung Cancer Diagnostics Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027
Africa
African Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2020 to 2027
Lung Cancer Diagnostics Market in Africa by Test: A Historic Review in US$ Thousand for 2012-2019
African Lung Cancer Diagnostics Market Share Breakdown by Test: 2012 VS 2020 VS 2027
African Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
Lung Cancer Diagnostics Market in Africa by Type: A Historic Review in US$ Thousand for 2012-2019
African Lung Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
African Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
Lung Cancer Diagnostics Historic Demand Patterns in Africa by End-Use in US$ Thousand for 2012-2019
Lung Cancer Diagnostics Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027
Total Companies Profiled : 48 (including Divisions/Subsidiaries - 48)

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com